Chapter: 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2: EXECUTIVE SUMMARY

2.1. CXO perspective

Chapter: 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets

3.3. Top player positioning/ market share analysis 2017
3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Rise in need for integrated data
3.4.1.2. Increase in growth in proteomics & genomics
3.4.1.3. Drug discovery and development

3.4.2. Restraints

3.4.2.1. Lack of skilled personnel
3.4.2.2. Common data formats

3.4.3. Opportunity

3.4.3.1. Increase in need for integrated solutions & systems

3.5. Porter's five forces analysis
3.6. Key Regulations
3.7. Value chain analysis
3.8. Bioinformatics in the drug development process
3.9. Patent analysis
3.10. Case studies

Chapter: 4: BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES

4.1. Overview

4.1.1. Market size and forecast

4.2. Knowledge Management Tools

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by type

4.2.2.1. Generalized knowledge management tools

4.2.2.1.1. Market size and forecast

4.2.2.2. Specialized knowledge management tools

4.2.2.2.1. Market size and forecast

4.2.3. Market size and forecast, by region
4.2.4. Market analysis, by country

4.3. Bioinformatics Platforms

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by type

4.3.2.1. Sequence analysis platforms

4.3.2.1.1. Market size and forecast

4.3.2.2. Sequence alignment platforms

4.3.2.2.1. Market size and forecast

4.3.2.3. Sequence manipulation platforms

4.3.2.3.1. Market size and forecast

4.3.2.4. Structural analysis platforms

4.3.2.4.1. Market size and forecast

4.3.2.5. Others

4.3.2.5.1. Market size and forecast

4.3.3. Market size and forecast, by region
4.3.4. Market analysis, by country

4.4. Bioinformatics Services

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by type

4.4.2.1. Sequencing services

4.4.2.1.1. Market size and forecast

4.4.2.2. Database and management

4.4.2.2.1. Market size and forecast

4.4.2.3. Data Analysis

4.4.2.3.1. Market size and forecast

4.4.2.4. Others

4.4.2.4.1. Market size and forecast

4.4.3. Market size and forecast, by region
4.4.4. Market analysis, by country

Chapter: 5: BIOINFORMATICS MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast, by region

5.2. Genomics

5.2.1. Metagenomics
5.2.2. Population genomics
5.2.3. Market size and forecast, by region
5.2.4. Market analysis, by country

5.3. Chemoinformatics and Drug Design

5.3.1. Market Size and Forecast, By Region
5.3.2. Market analysis, by country

5.4. Proteomics

5.4.1. Market Size and Forecast, by region
5.4.2. Market analysis, by country

5.5. Transcriptomics

5.5.1. Market size and forecast
5.5.2. Market analysis, by country

5.6. Metabolomics

5.6.1. Market size and forecast
5.6.2. Market analysis, by country

5.7. Molecular Phylogenetics

5.7.1. Market size and forecast
5.7.2. Market analysis, by country

5.8. Other application market

5.8.1. Pharmacogenomics
5.8.2. Pharmacoproteomics

5.8.2.1. Market size and forecast

5.8.3. Market analysis, by country

Chapter: 6: GLOBAL BIOINFORMATICS MARKET BY SECTOR

6.1. Overview

6.1.1. Market size and forecast, by region

6.2. Medical bioinformatics

6.2.1. Drug development
6.2.2. Molecular medicine
6.2.3. Preventive medicine
6.2.4. Gene therapy
6.2.5. Market size and forecast, by region
6.2.6. Market analysis, by country

6.3. Animal Bioinformatics

6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country

6.4. Agricultural bioinformatics

6.4.1. Crop yield improvement
6.4.2. Pest resistance
6.4.3. Plant resistance against abiotic stresses
6.4.4. Improve nutritional quality
6.4.5. Market size and forecast by region
6.4.6. Market analysis, by country

6.5. Academics

6.5.1. Market size and forecast, by region
6.5.2. Market analysis, by country

6.6. Others (Microbial genome)

6.6.1. Market size and forecast, by region
6.6.2. Market analysis, by country

Chapter: 7: BIOINFORMATICS MARKET, BY REGION

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key market trends and opportunities
7.2.2. North America bioinformatics market, by country

7.2.2.1. U.S. bioinformatics market, by technology and services
7.2.2.2. U.S. bioinformatics market, by application
7.2.2.3. U.S. bioinformatics market, by sector
7.2.2.4. Canada bioinformatics market, by technology and services
7.2.2.5. Canada bioinformatics market, by Application
7.2.2.6. Canada bioinformatics market, by sector
7.2.2.7. Mexico bioinformatics market, by technology and services
7.2.2.8. Mexico bioinformatics market, by application
7.2.2.9. Mexico bioinformatics market, by sector

7.2.3. North America bioinformatics market, by technology and services
7.2.4. North America bioinformatics market, by Application
7.2.5. North America bioinformatics market, by Sector

7.3. Europe

7.3.1. Key market trends and opportunities
7.3.2. Europe bioinformatics market, by country

7.3.2.1. Germany bioinformatics market, by technology and services
7.3.2.2. Germany bioinformatics market, by application
7.3.2.3. Germany bioinformatics market, by sector
7.3.2.4. France bioinformatics market, by technology and services
7.3.2.5. France bioinformatics market, by application
7.3.2.6. France bioinformatics market, by sector
7.3.2.7. UK bioinformatics market, by technology and services
7.3.2.8. UK bioinformatics market, by application
7.3.2.9. UK bioinformatics market, by sector
7.3.2.10. Italy bioinformatics market, by technology and services
7.3.2.11. Italy bioinformatics market, by application
7.3.2.12. Italy bioinformatics market, by sector
7.3.2.13. Spain bioinformatics market, by technology and services
7.3.2.14. Spain bioinformatics market, by application
7.3.2.15. Spain bioinformatics market, by sector
7.3.2.16. Rest of Europe bioinformatics market, by technology and services
7.3.2.17. Rest of Europe bioinformatics market, by application
7.3.2.18. Rest of Europe bioinformatics market, by sector

7.3.3. Europe bioinformatics market, by technology and services
7.3.4. Europe bioinformatics market, by application
7.3.5. Europe bioinformatics market, by sector

7.4. Asia-Pacific

7.4.1. Key market trends and opportunities
7.4.2. Asia-Pacific bioinformatics market, by country

7.4.2.1. Japan bioinformatics market, by technology and services
7.4.2.2. Japan bioinformatics market, by Application
7.4.2.3. Japan bioinformatics market, by sector
7.4.2.4. China bioinformatics market, by technology and services
7.4.2.5. China bioinformatics market, by application
7.4.2.6. China bioinformatics market, by sector
7.4.2.7. India bioinformatics market, by technology and services
7.4.2.8. India bioinformatics market, by application
7.4.2.9. India bioinformatics market, by sector
7.4.2.10. Australia bioinformatics market, by technology and services
7.4.2.11. Australia bioinformatics market, by application
7.4.2.12. Australia bioinformatics market, by sector
7.4.2.13. South Korea bioinformatics market, by technology and services
7.4.2.14. South Korea bioinformatics market, by application
7.4.2.15. South Korea bioinformatics market, by sector
7.4.2.16. Taiwan bioinformatics market, by technology and services
7.4.2.17. Taiwan bioinformatics market, by Application
7.4.2.18. Taiwan bioinformatics market, by sector
7.4.2.19. Rest of Asia-Pacific bioinformatics market, by technology and services
7.4.2.20. Rest of Asia-Pacific bioinformatics market, by application
7.4.2.21. Rest of Asia-Pacific bioinformatics market, by sector

7.4.3. Asia-Pacific bioinformatics market, by technology and services
7.4.4. Asia-Pacific bioinformatics market, by application
7.4.5. Asia-Pacific bioinformatics market, by sector

7.5. LAMEA

7.5.1. Key market trends and opportunities
7.5.2. LAMEA bioinformatics market, by country

7.5.2.1. Brazil bioinformatics market, by technology and services
7.5.2.2. Brazil bioinformatics market, by application
7.5.2.3. Brazil bioinformatics market, by sector
7.5.2.4. Saudi Arabia bioinformatics market, by technology and services
7.5.2.5. Saudi Arabia bioinformatics market, by application
7.5.2.6. Saudi Arabia bioinformatics market, by sector
7.5.2.7. South Africa bioinformatics market, by technology and services
7.5.2.8. South Africa bioinformatics market, by application
7.5.2.9. South Africa bioinformatics market, by sector
7.5.2.10. Rest of LAMEA bioinformatics market, by technology and services
7.5.2.11. Rest of LAMEA bioinformatics market, by application
7.5.2.12. Rest of LAMEA bioinformatics market, by sector

7.5.3. LAMEA bioinformatics market, by technology and services
7.5.4. LAMEA bioinformatics market, by application
7.5.5. LAMEA bioinformatics market, by sector

Chapter: 8: COMPANY PROFILES

8.1. AGILENT TECHNOLOGIES, INC.

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments

8.2. BIOMAX INFORMATICS AG

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product Portfolio
8.2.5. Key strategic moves and developments

8.3. BRUKER CORPORATION

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments

8.4. DASSAULT SYSTEMES

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product Portfolio
8.4.5. Business performance

8.5. EUROFINS SCIENTIFIC

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Product portfolio
8.5.4. Business performance

8.6. GENEVA BIOINFORMATICS (GENEBIO) S.A.

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio

8.7. ILLUMINA, INC.

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments

8.8. PERKINELMER INC.

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments

8.9. QIAGEN N.V.

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Product portfolio
8.9.4. Business performance
8.9.5. Key strategic moves and developments

8.10. THERMO FISHER SCIENTIFIC, INC.

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments